Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer (Q42461856)

1 November 2017

Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer (English)

1 reference

triple-negative breast cancer

1 November 2017

1 reference

1 reference

Aye Aye Thike

1

1 reference

1 November 2017

Poh Yian Cheok

2

1 reference

1 November 2017

Ana Richelia Jara-Lazaro

3

1 reference

1 November 2017

Benita Tan

4

1 reference

1 November 2017

Patrick Tan

5

1 reference

1 November 2017

Puay Hoon Tan

6

1 reference

1 November 2017

language of work or name

1 reference

23 October 2009

1 reference

1 November 2017

1 reference

1 November 2017

23

1 reference

1 November 2017

1

1 reference

1 November 2017

123-133

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2009.145

1 November 2017

0 references

cites work

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

Prognostic markers in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

Concordance among gene-expression-based predictors for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

Prognostic ability of a panel of immunohistochemistry markers - retailoring of an 'old solution'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6'split apart' probes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

Clinicopathologic and prognostic characteristics of triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

Triple-negative breast carcinoma in women from Vietnam and the United States: characterization of differential marker expression by tissue microarray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

Demystifying basal-like breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

Triple-negative/basal-like breast cancer: review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

7 January 2021

Triple negative tumours: a critical review

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

7 January 2021

Clinical validation of a customized multiple signature microarray for breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

7 January 2021

[Validation of the Düsseldorfer screening tool: a trait-based approach to assess psychological distress of cancer patients]

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

7 January 2021

Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

7 January 2021

Basal cytokeratin expression in relation to immunohistochemical and clinical characterization in breast cancer patients with triple negative phenotype.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.145

7 January 2021

10.1038/MODPATHOL.2009.145

Identifiers

DOI

1 reference

Dimensions Publication ID

1 November 2017

0 references

1 reference